{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:39:33Z","timestamp":1767148773147,"version":"build-2238731810"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK048489"],"award-info":[{"award-number":["DK048489"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health"},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000124","name":"Office of Research on Women\u2019s Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000124","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Center for Minority Health and Human Disease"},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001009","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006687","name":"Parke-Davis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006687","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health"},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000124","name":"Office of Research on Women\u2019s Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000124","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Center for Minority Health and Human Disease"},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001009","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006687","name":"Parke-Davis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006687","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.metabol.2015.11.011","type":"journal-article","created":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T08:32:15Z","timestamp":1449045135000},"page":"764-775","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the Diabetes Prevention Program"],"prefix":"10.1016","volume":"65","author":[{"given":"Ronald B.","family":"Goldberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marinella","family":"Temprosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Mele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor","family":"Orchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kieren","family":"Mather","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Bray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Horton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Kitabchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Krakoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santica","family":"Marcovina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leigh","family":"Perreault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7134","key":"10.1016\/j.metabol.2015.11.011_bb0005","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/bmj.316.7134.823","article-title":"Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)","volume":"316","author":"Turner","year":"1998","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.metabol.2015.11.011_bb0010","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.2337\/diacare.28.10.2472","article-title":"Lipid, lipoproteins, C-reactive protein, and hemostatic factors at baseline in the Diabetes Prevention Program","volume":"28","author":"The Diabetes Prevention Program Research Group","year":"2005","journal-title":"Diabetes Care"},{"issue":"21","key":"10.1016\/j.metabol.2015.11.011_bb0015","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1001\/jama.1990.03440210043030","article-title":"Hazuda Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?","volume":"263","author":"Haffner","year":"1990","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.metabol.2015.11.011_bb0020","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Diabetes Prevention Program Research Group","year":"2002","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.metabol.2015.11.011_bb0025","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1210\/jc.2013-1452","article-title":"Lifestyle and metformin treatment favorably influence lipoprotein sub-fraction distribution in the Diabetes Prevention Program","volume":"98","author":"Goldberg","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.metabol.2015.11.011_bb0030","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1161\/ATVBAHA.107.160192","article-title":"Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome","volume":"28","author":"Adiels","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.metabol.2015.11.011_bb0035","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/01.mol.0000236367.42755.c1","article-title":"Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular disease","volume":"17","author":"Packard","year":"2006","journal-title":"Curr Opin Lipidol"},{"issue":"4","key":"10.1016\/j.metabol.2015.11.011_bb0040","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00125-003-1074-z","article-title":"Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex","volume":"46","author":"Cnop","year":"2003","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.metabol.2015.11.011_bb0045","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.2337\/dc09-0084","article-title":"Adiponectin and lipoprotein particle size","volume":"32","author":"Weiss","year":"2009","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.metabol.2015.11.011_bb0050","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jacl.2012.04.004","article-title":"Health benefits of high-density lipoproteins in preventing cardiovascular diseases","volume":"6","author":"Berrougui","year":"2012","journal-title":"J Clin Lipidol"},{"issue":"7","key":"10.1016\/j.metabol.2015.11.011_bb0055","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2337\/diacare.20.7.1183","article-title":"Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus","volume":"20","year":"1997","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.metabol.2015.11.011_bb0060","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S1047-2797(98)00070-2","article-title":"Validity and reproducibility of a food frequency interview in a multi-cultural epidemiology Study","volume":"9","author":"Mayer-Davis","year":"1999","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.metabol.2015.11.011_bb0065","series-title":"Centers for Disease Control and Prevention","first-page":"S5","article-title":"Introduction to the collection of physical activity questionnaires in a collection of physical activity questionnaires for health-related research","volume":"29","author":"Kriska","year":"1997"},{"issue":"12","key":"10.1016\/j.metabol.2015.11.011_bb0070","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/oxfordjournals.aje.a010187","article-title":"Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies","volume":"151","author":"Hanson","year":"2000","journal-title":"Am J Epidemiol"},{"issue":"9","key":"10.1016\/j.metabol.2015.11.011_bb0075","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1093\/clinchem\/38.9.1632","article-title":"Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement","volume":"38","author":"Otvos","year":"1992","journal-title":"Clin Chem"},{"issue":"4","key":"10.1016\/j.metabol.2015.11.011_bb0080","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cll.2006.07.006","article-title":"Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy","volume":"26","author":"Jeyarajah","year":"2006","journal-title":"Clin Lab Med"},{"issue":"3","key":"10.1016\/j.metabol.2015.11.011_bb0085","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ehj.2003.11.004","article-title":"Tissue plasminogen activator antigen and coronary heart disease: prospective study and meta-analysis","volume":"25","author":"Lowe","year":"2004","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.metabol.2015.11.011_bb0090","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1210\/jc.2008-1457","article-title":"Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-I kinetics in obese and nonobese men","volume":"94","author":"Chan","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.metabol.2015.11.011_bb0095","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.bbrc.2007.05.040","article-title":"Adiponectin accelerates reverse cholesterol transport by increasing high density lipoprotein assembly in the liver","volume":"358","author":"Matsuura","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.metabol.2015.11.011_bb0100","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.atherosclerosis.2012.06.062","article-title":"Plasminogen activator inhitor-1 associates with cardiovascular risk factors in healthy young adults in the Cardiovascular Risk in Young Finns Study","volume":"224","author":"Raiko","year":"2012","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.metabol.2015.11.011_bb0105","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/01.RES.0000146094.59640.13","article-title":"Antiinflammatory properties of HDL","volume":"95","author":"Barter","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2015.11.011_bb0110","doi-asserted-by":"crossref","unstructured":"Lihn AS, Bruun JM, He G, Pedersen SB, Jensen PF, Richelsen B. Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol 219(1\u20132): 9\u201315.","DOI":"10.1016\/j.mce.2004.03.002"},{"issue":"4","key":"10.1016\/j.metabol.2015.11.011_bb0115","doi-asserted-by":"crossref","first-page":"980","DOI":"10.2337\/db07-1419","article-title":"Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program","volume":"57","author":"Mather","year":"2008","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.metabol.2015.11.011_bb0120","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1210\/en.2010-0530","article-title":"Adiponectin increases LPL activity via RhoA\/ROCK-mediated actin remodelling in adult rat cardiomyocytes","volume":"152","author":"Ganguly","year":"2011","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.metabol.2015.11.011_bb0125","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0009-8981(81)90455-1","article-title":"High density lipoprotein subfractions in relation to lipoprotein lipase activity of tissues in man--evidence for reciprocal regulation of HDL2 and HDL3 levels by lipoprotein lipase","volume":"112","author":"Taskinen","year":"1981","journal-title":"Clin Chim Acta"},{"issue":"2","key":"10.1016\/j.metabol.2015.11.011_bb0130","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.atherosclerosis.2010.01.001","article-title":"Impact of HDL on adipose tissue metabolism and adiponectin expression","volume":"210","author":"Van Linthout","year":"2010","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1016\/j.metabol.2015.11.011_bb0135","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1194\/jlr.M030213","article-title":"Adiponectin and the mediation of HDL-cholesterol change with improved lifestyle: the Look AHEAD Study","volume":"53","author":"Belalcazar","year":"2012","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1016\/j.metabol.2015.11.011_bb0140","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.atherosclerosis.2012.02.032","article-title":"Inflammation modulates human HDL composition and function in vivo","volume":"222","author":"de la Llera","year":"2012","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.metabol.2015.11.011_bb0145","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1210\/jcem.86.2.7410","article-title":"Framingham Heart Study. Increased PAI-1 and tPA antigen levels are reduced with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance","volume":"86","author":"Hadigan","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl. 1","key":"10.1016\/j.metabol.2015.11.011_bb0150","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.2337\/dc15-S008","article-title":"Prevention or Delay of Type 2 Diabetes","volume":"38","author":"American Diabetes Association Position Statement","year":"2015","journal-title":"Diabetes Care"},{"issue":"Suppl. 1","key":"10.1016\/j.metabol.2015.11.011_bb0155","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1055\/s-0029-1240928","article-title":"A European evidence-based guideline for the prevention of type 2 diabetes","volume":"42","author":"Paulweber","year":"2010","journal-title":"Horm Metab Res"}],"updated-by":[{"DOI":"10.1016\/j.metabol.2016.11.007","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000}}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049515003650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049515003650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:12:23Z","timestamp":1758427943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049515003650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0026049515003650"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2015.11.011","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the Diabetes Prevention Program","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2015.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}